Dongzi Yang

Dongzi Yang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Aging
Verified
Journal Article
Open access
MTMin Tan
Min Tan
YCYanxiang Cheng
Yanxiang Cheng
XZXiaozhu Zhong
Xiaozhu Zhong
DYDongyong Yang
Dongyong Yang
SJSushi Jiang
Sushi Jiang
XZXiaomiao Zhao
Xiaomiao Zhao
Polycystic ovary syndrome (PCOS), which is often accompanied by insulin resistance, is closely related to increased apoptosis of ovarian granulosa cells. LNK is an important regulator of the insulin signaling pathway. When insulin binds to the receptor, the PI3K/AKT/FOXO signaling pathway is activated, and FOXO translocates from the nucleus to the cytoplasm, thereby inhibiting the expression of pro-apoptotic genes. Granulosa cells were collected from PCOS patients to investigate the relationship between LNK, cell apoptosis and insulin resistance. KGN cells underwent LNK overexpression/silence and insulin stimulation. The AKT/FOXO3 pathway was studied by western blot and immunofluorescence. LNK knockout mice were used to investigate the effect of LNK on the pathogenesis of PCOS. The level of LNK was higher in PCOS group than control group. LNK was positively correlated with granulosa cell apoptosis and insulin resistance, and negatively correlated with oocyte maturation rate. LNK overexpression in KGN cells inhibited insulin-induced AKT/FOXO3 signaling pathway, causing nucleus translocation of FOXO3 and promoting granulosa cell apoptosis. LNK knockout partially restored estrous cycle and improved glucose metabolism in PCOS mice. LNK was closely related to insulin resistance and apoptosis of granulosa cells via the AKT/FOXO3 pathway. LNK knockout partially restored estrous cycle and improved glucose metabolism in PCOS mice, suggesting LNK might become a potential biological target for the clinical treatment of PCOS.

1 March 2014 in Reproductive Sciences
Verified
Journal Article
Closed access
YLYu Li
Yu Li
PPPing Pan
Ping Pan
XCXiaoli Chen
Xiaoli Chen
LLLin Li
Lin Li
YLYi Li
Yi Li
DYDongzi Yang
Dongzi Yang

8 February 2017 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
PYPing Yuan
Ping Yuan
ZHZuyong He
Zuyong He
LZLingyan Zheng
Lingyan Zheng
WWWenjun Wang
Wenjun Wang
YLYu Li
Yu Li
DYDongzi Yang
Dongzi Yang
Empty follicle syndrome (EFS) is a reproductive disorder in which no oocytes are retrieved during IVF. The existence of genuine EFS (GEFS) is still controversial, and to date, only one missense mutation of Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR) has been reported to be associated with this disease. Here, we describe a GEFS patient in a non-consanguineous family from China. A 27-year-old woman presented with a 5-year history of primary infertility and LH resistance-like ovaries of unequal sizes, but with normal levels of circulating LH. In spite of a satisfactory ovarian reserve and response, no oocytes were retrieved after two cycles of IVF. Her condition did not appear to be failure of the hCG injection. It is more likely to be a genetic cause. A novel homozygous mutation in LHCGR gene, c.1345G>A (p.Ala449Thr), was detected in this patient. Each of her parents is heterozygous for this change, and the change was absent from 407 control subjects. Alanine at this amino acid position was highly conserved and replacement of threonine was predicted to disrupt the third transmembrane helix of the rhodopsin-like G protein-coupled receptor domain. Protein localization studies revealed that a portion of the mutant LHCGR protein molecules was retained intracellularly. Signalling studies demonstrated that this mutation had differing effects on the response of LHCGR to hCG or LH at different concentrations. Specifically, at a concentration 1 IU/ml), the mutant was activated by both hCG and LH. These data suggest that screening for mutations in the LHCGR gene may assist in the diagnosis of patients with GEFS. The literature describing the relationship between phenotype and genotypes in females is reviewed, and possible aetiologies and treatment options for this disease are proposed based on our and other studies.

18 February 2010 in Human Reproduction
Verified
Journal Article
Open access
PDF file
XCXiaoli Chen
Xiaoli Chen
RNRenmin Ni
Renmin Ni
YMYaqin Mo
Yaqin Mo
LLLin Li
Lin Li
DYDongzi Yang
Dongzi Yang
This study was designed to establish appropriate body mass index (BMI) level for PCOS women and to compare metabolic abnormalities between PCOS women and control women in Southern China. This clinical cross-sectional study included 999 PCOS patients (857 adults and 142 adolescents) and 922 age-matched controls (742 adults and 180 adolescents). The proportion of PCOS patients with a BMI above 23 kg/m2 was 34.63%. Serum insulin, triglycerides, waist and waist/hip (W/H) measurements were all correlated positively with BMI in PCOS women. Prevalence of metabolic syndrome in Chinese PCOS patients was 18.9%. Receiver-operating characteristic analysis suggested that at the point of BMI ≥23 kg/m2, the diagnostic power to detect metabolic disorders was at its best. PCOS patients with a BMI of 23 kg/m2 or beyond may have a higher risk of metabolic disorders. Using an appropriate BMI level may help to improve attention to metabolic disorders among PCOS patients in Southern China.

20 January 2015 in Chinese Medical Journal
Verified
Journal Article
Open access
PDF file
LLLin Lin
Lin Lin
TDTao Du
Tao Du
JHJia Huang
Jia Huang
LHLi-Li Huang
Li-Li Huang
DYDongzi Yang
Dongzi Yang
Background: Polycystic ovary syndrome (PCOS) is the commonest endocrinopathy in women of reproductive age. The patients often develop insulin resistance (IR) or hyperinsulinemia despite manifesting anovulation and signs of hyperandrogenism. The cause and effect relationship of hyperinsulinemia and hyperandrogenemia (HA) is still debated. Micro-ribonucleic acids (miRNAs) have recently been shown to play a role in regulation of ovarian function. Our current study focused on the altered expression of miRNAs with PCOS. Methods: Ovarian theca interna tissues were obtained from 10 PCOS patients and 8 controls that were non-PCOS and had normal insulin sensitivity undergoing laparoscopy and/or ovarian wedge resection. Total RNA of all samples was extracted. We studied the repertoire of miRNAs in both PCOS and non-PCOS women by microarray hybridization. Bioinformatic analysis was performed for predicting targets of the differentially expressed miRNAs. Furthermore, selected miRNAs were validated by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Results: A total of 27 miRNAs were differentially expressed in PCOS patients with respect to the controls in our discovery evaluationand two (miR-92a and miR-92b) of them were significantly downregulated in PCOS women in followed validation (P < 0.05). Targets prediction revealed that miR-92a targeted both GATA family of zinc finger transcription factor GATA-binding factor 6 (GATA6) and insulin receptor substrate proteins 2 (IRS-2). Conclusions: MiRNAs are differentially expressed between PCOS patients and controls. We identified and validated two miRNAs-miR-92a and miR-92b. They are significantly downregulated and may be involved in the pathogenesis of PCOS.

4 September 2008 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
YCY. Chen
Y. Chen
LLL. Li
L. Li
XCX. Chen
X. Chen
QZQ. Zhang
Q. Zhang
WWW. Wang
W. Wang
DYDongzi Yang
Dongzi Yang
Objective: To assess the value of ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome (PCOS) in a Chinese population.Methods: This study included 432 women with PCOS selected using the National Institutes of Health criteria, who were compared with 153 age‐matched women as controls. All participants were given a transvaginal or transrectal ultrasound scan during day 3–5 of the menstrual cycle (for regularly menstruating women) or randomly (for oligomenorrheic or amenorrheic women). The ovarian volume (calculated using the simplified formula: 0.5 × length × height × width) and follicle number were obtained and the best diagnostic cut‐off values were evaluated using receiver–operating characteristics (ROC)‐curve analysis.Results: The 10th and 90th centiles of ovarian volume in PCOS patients were 4.89 and 15.79 cm3, respectively, and the median was 9.21 cm3; the 10th and 90th centiles of follicle number were 8 and 19, respectively, and the median was 12. The 10th and 90th centiles of ovarian volume in controls were 2.43 and 7.75 cm3, respectively, and the median was 4.46 cm3; the 10th and 90th centiles of follicle number were 3 and 10, respectively, and the median was 6. The differences in ovarian volume and follicle number between patients and controls were statistically significant. The areas under the ROC curves for mean ovarian volume (MOV), maximum ovarian volume (MaxOV), mean follicle number (MFN) and maximum follicle number (MaxFN) to diagnose PCOS were 0.898, 0.882, 0.909 and 0.911, respectively. Setting the threshold for MOV at 6.4 cm3 (sensitivity 81%, specificity 85.6%), the threshold for MaxOV at 7.9 cm3 (sensitivity 78%, specificity 85.6%), the threshold for MFN at 10 (sensitivity 85.2%, specificity 88.8%) and the threshold for MaxFN at 12 (sensitivity 85.2%, specificity 92.6%) obtained the best compromise between sensitivity and specificity, based on the Youden index.Conclusions: We conclude that ovarian volume and follicle number have satisfactory power for use in the diagnosis of PCOS. Cut‐offs of 6.4 cm3, 7.9 cm3, 10 and 12, for MOV, MaxOV, MFN and MaxFN, respectively, obtained the best compromise between sensitivity and specificity for the diagnosis of PCOS in Chinese women. Copyright © 2008 ISUOG. Published by John Wiley & Sons, Ltd.